Pancreatic Cancer Research

ResearcherThe Catholic University of Korea St. Vincent's HospitalNo recent work listed

Byoung Yong Shim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6473-786X; OpenAlex author ID A5011357776. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Efficacy of dabrafenib/trametinib in pancreatic ductal adenocarcinoma with BRAF NVTAP deletion: A case report. Last author DOI 10.3389/fonc.2022.976450↗
  2. A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer. Co-author DOI 10.7150/jca.50514↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ji Eun Shin · 1 shared paper, 2022 · strength 0.20
  2. Hunho Song · 1 shared paper, 2021 · strength 0.11
  3. Boram Han · 1 shared paper, 2021 · strength 0.11
  4. Jin Won Kim · 1 shared paper, 2021 · strength 0.11
  5. Dae Young Zang · 1 shared paper, 2021 · strength 0.11
  6. Jung Han Kim · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.